Huge thanks to Ameish Govindarajan, MD Montessa M. Lee Donnita, Dan & Aurora - the heart & soul of our panel. Their authenticity & willingness to share not only enriched #NLCRT23 but also left an impact on the broader conversation around patient-centered research & care! #LCSM

This is truly one of my favorite parts of City of Hope — getting to work on cutting edge GU oncology research with these rockstars 🤩 a HUGE thank you to Sumanta K. Pal, MD, FASCO and Tanya Dorff for your invaluable mentorship and support 🙏🏼 very excited for what the year to come has in store! 📈

Just In Kidney Cancer: Real-world study shows tumor-specific gene expression by RNA sequencing could serve as a potential biomarker of response to ipi + nivo Rx for mRCC #kidneycancer @tripNish Neeraj Agarwal, MD, FASCO Sumanta K. Pal, MD, FASCO👉tinyurl.com/mr3xfutf OncoAlert KidneyCAN UroToday.com

So proud of the superteam of Tanya Dorff & Saul “Cancer Asskicker” Priceman - what an amazing paper in Nature Medicine. Have witnessed this duo forging the ultimate clinical/translational partnership in conducting this study over almost a decade. We often talk about #benchtobedside, but this is a

Tomorrow! Join the NCI Office of Cancer Survivorship during #NationalCancerSurvivorsMonth for a webinar, "Survivor Voices: The Vital Role of Survivors in Advancing Cancer Survivorship Research" Tuesday, June 18 at 2 pm ET. spr.ly/6014efGHI

It's with great pleasure that I share with you our paper evaluating #cabozantinib with #nivolumab +/- #CBM588 in pts with advanced #kidneycancer, published today in Nature Medicine! 🙏Huge thanks 1st/foremost to patients & their families. Had tons of support from the amazing

Our study in JCO Global Oncology explores financial toxicity & unmet social needs in cancer care across HIC & LMIC Alex Chan, PharmD, MPH Charles Jiang MD, MPH Ana I. Velázquez Mañana, MD, MSc, FASCO Enrique Soto & cols MASCC survey reveals disparities in cost burdens and support availability ascopubs.org/doi/pdfdirect/…

Combining telehealth & ePROs is transforming oncology with enhanced accessibility, quality, and patient satisfaction Read more about these innovations in our latest post at ASCO Post, co-written w Mazie Tsang, MD, MAS, MS Ramy Sedhom, MD, FASCO #ASCODailyNews #ASCOQLTY24 dailynews.ascopubs.org/do/advancing-e…

Agree with Sumanta K. Pal, MD, FASCO huge news & congrats to Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute for leading this important practice impacting trial! Great news for patients! @NeliMUlrich Prostate Cancer Foundation OncoAlert UroToday.com Oncology Brothers Emmanuel Antonarakis Jessica Hawley MD MS Marinos Tsiatas GU Oncology Now Vivek Subbiah, MD

Got the most wonderful message from Ameish Govindarajan, MD in the middle of a v busy clinic on Wednesday. After finishing his #PalliativeCare fellowship at Memorial Sloan Kettering Cancer Center. Enjoyed working with him at City of Hope & incredibly excited to see what he will accomplish at the storied

Congrats to Ameish Govindarajan, MD Sawyer Bawek, DO and company Cleveland Clinic MD. You have excellent company Jasmin Hundal, M.D., DipABLM, M.S., M.P.H. #pallonc #supponc #survonc

Ameish Govindarajan joins Cleveland Clinic MD for Hematology Oncology Fellowship Ameish Govindarajan, MD CCF Hematology Oncology Fellows Sumanta K. Pal, MD, FASCO Tanya Dorff Betty Ferrell Craig Blinderman, MD, MA Memorial Sloan Kettering Cancer Center oncodaily.com/blog/206188 #Cancer #CCF #OncoDaily #Oncology #MSKCC

Kidney cancer Powerhouses Laurence Albiges and Sumanta K. Pal, MD, FASCO hosted by KidneyCAN for a special seminar on the latest research in Kidney cancer--Can't miss this one! LINK: kidneycan.org/latest-kidney-… Bryan Lewis Brian Rini, MD Brian Shuch, MD Tom Powles Gustave Roussy City of Hope

Mindfulness via smartphone AmDTx Mentored by Sumanta K. Pal, MD, FASCO & Dr. Linda E. Carlson 🇨🇦 🇨🇦, this multinational study demonstrates that a mindfulness app improves emotional symptoms, fatigue, & QOL in patients w mRCC on IO ‼️Accessible, feasible, & impactful! academic.oup.com/oncolo/article…

Cristiane D Bergerot et al in The Oncologist #pallonc #supponc Mindfulness app 🧘📲 for #kcsm on #IO: ⬆️feasibility (96% retained) ⬆️ adherence (75%) ⬆️ emotional symptoms 😄 ⬇️ fatigue🪫➡️🔋 ⬆️quality of life (P = .001). Accessible #psyonc support! 🔗: academic.oup.com/oncolo/article…

🧵 1/7 Newly published Journal of Clinical Oncology #OncologyAdvances! Our study explores how insurance status affects survival outcomes for patients with metastatic renal cell carcinoma (mRCC) receiving first-line systemic therapy. Read here: doi.org/10.1200/OA.24.…

Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung Carcinoma ascopubs.org/doi/10.1200/PO… This large genomic profiling study analyzed data from 149 patients with small cell bladder cancer (SCBC),